On ECHEMI
Home > Drugs > Haier Blood Technology Chongqing Co., Ltd.
Haier Blood Technology Chongqing Co., Ltd.
  • Founded in:

    2001-08-30
  • Country:

    China China
  • Address:

    No. 21, East Section of Changzhou Avenue, Changzhou Street, Rongchang District, Chongqing
  • Tax NO.:

    91500108709427765Y
  • Registered Funds:

    5.2367 million yuan
  • Website:

  • Email:

Related Drugs
Red blood cell storage solution
Name Description Content CAS NO. Registered Holders
ALSEVER'S SOLUTION

0
Red blood cell storage solution
Name Description Content CAS NO. Registered Holders
ALSEVER'S SOLUTION

For storage of red blood cells

More

For storage of red blood cells

0
Blood preservation solution Ⅲ
Name Description Content CAS NO. Registered Holders
Blood preservation solution Ⅲ

0
Blood preservation solution Ⅱ
This product is a compound preparation, and its main components of 1000ml are: sodium citrate (C6H5O7Na3·2H2O) 22.0g, citric acid (C6H8O7·H2O) 8.0g, and glucose (C6H12O6·H2O) 24.5g.
Name Description Content CAS NO. Registered Holders
Trisodium citrate dihydrate

Citrate ions react with calcium ions in the blood to form a soluble complex, calcium citrate, which is difficult to dissociate, reducing calcium ions in the blood and inhibiting the coagulation process; at the same time, they form a buffer pair with citric acid to adjust and stabilize the pH of the solution; and they are completely oxidized and metabolized in the tricarboxylic acid cycle.

More

Citrate ions react with calcium ions in the blood to form a soluble complex, calcium citrate, which is difficult to dissociate, reducing calcium ions in the blood and inhibiting the coagulation process; at the same time, they form a buffer pair with citric acid to adjust and stabilize the pH of the solution; and they are completely oxidized and metabolized in the tricarboxylic acid cycle.

22.0g 6132-04-3 32
Citric acid monohydrate

It forms a buffer pair with sodium citrate to adjust and stabilize the pH of the solution; it participates in the formation of calcium citrate to inhibit blood coagulation.

More

It forms a buffer pair with sodium citrate to adjust and stabilize the pH of the solution; it participates in the formation of calcium citrate to inhibit blood coagulation.

8.0g 5949-29-1 39
GLUCOSE

As a nutrient, it provides energy and maintains the osmotic pressure balance of the solution.

More

As a nutrient, it provides energy and maintains the osmotic pressure balance of the solution.

24.5g 58367-01-4 15
Sodium Citrate Injection for Blood Transfusion
Sodium 2-hydroxypropane-1,2,3-tricarboxylate dihydrate
Name Description Content CAS NO. Registered Holders
Trisodium citrate dihydrate

Citrate ions react with calcium ions in the blood to form a soluble complex, calcium citrate, which is difficult to dissociate, reducing calcium ions in the blood, inhibiting the coagulation process and thus preventing blood coagulation. When used as an in vitro anticoagulant, it generally does not produce adverse reactions if the liver function is normal and the blood is transfused at an appropriate rate.

More

Citrate ions react with calcium ions in the blood to form a soluble complex, calcium citrate, which is difficult to dissociate, reducing calcium ions in the blood, inhibiting the coagulation process and thus preventing blood coagulation. When used as an in vitro anticoagulant, it generally does not produce adverse reactions if the liver function is normal and the blood is transfused at an appropriate rate.

6132-04-3 32
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.